|
Volumn 167, Issue 5, 2013, Pages
|
Erdheim-Chester disease with cardiac involvement successfully treated with anakinra
|
Author keywords
Anakinra; Chemotherapy; Erdheim Chester; Histiocytosis; Non Langerhans; Right atrium
|
Indexed keywords
ALPHA INTERFERON;
C REACTIVE PROTEIN;
RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT;
AGED;
BLOOD VESSEL BIOPSY;
CARDIOVASCULAR MAGNETIC RESONANCE;
CASE REPORT;
CLINICAL FEATURE;
COMPUTED TOMOGRAPHIC ANGIOGRAPHY;
DISEASE ASSOCIATION;
DRUG EFFICACY;
DRUG SAFETY;
DRUG TOLERABILITY;
ERDHEIM CHESTER DISEASE;
ERYTHROCYTE SEDIMENTATION RATE;
FOLLOW UP;
HEART ATRIUM THROMBOSIS;
HISTIOCYTE;
HUMAN;
HUMAN TISSUE;
LETTER;
MALE;
MEDICAL HISTORY;
OUTCOME ASSESSMENT;
POSITRON EMISSION TOMOGRAPHY;
PRIORITY JOURNAL;
SINUS TACHYCARDIA;
SYNDROME DELINEATION;
SYSTOLIC HEART MURMUR;
TEMPORAL ARTERITIS;
TISSUE CHARACTERIZATION;
TRANSESOPHAGEAL ECHOCARDIOGRAPHY;
UNSPECIFIED SIDE EFFECT;
ANAKINRA;
CHEMOTHERAPY;
ERDHEIM-CHESTER;
HISTIOCYTOSIS;
NON-LANGERHANS;
RIGHT ATRIUM;
AGED;
ERDHEIM-CHESTER DISEASE;
HEART ATRIA;
HEART DISEASES;
HUMANS;
INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN;
MALE;
TREATMENT OUTCOME;
|
EID: 84883301842
PISSN: 01675273
EISSN: 18741754
Source Type: Journal
DOI: 10.1016/j.ijcard.2013.04.057 Document Type: Article |
Times cited : (37)
|
References (10)
|